| Literature DB >> 34160666 |
Thomas Gehrke1, Agmal Scherzad2, Rudolf Hagen2, Stephan Hackenberg2.
Abstract
PURPOSE: Infections of the deep neck, although becoming scarcer due to the widespread use of antibiotics, still represent a dangerous and possibly deadly disease, especially when descending into the mediastinum. Due to the different specialities involved in the treatment and the heterogenous presentation of the disease, therapeutic standard is still controversial. This study analyzes treatment and outcome in these patients based on a large retrospective review and proposes a therapeutic algorithm.Entities:
Keywords: Deep neck infection; Mediastinitis; Microbiology; Surgical drainage; Tracheotomy
Mesh:
Year: 2021 PMID: 34160666 PMCID: PMC8897324 DOI: 10.1007/s00405-021-06945-9
Source DB: PubMed Journal: Eur Arch Otorhinolaryngol ISSN: 0937-4477 Impact factor: 2.503
Baseline patient characteristics and initial clinical findings in patients with and without mediastinal involvement of a deep neck infection
| No mediastinal involvement | Mediastinal involvement | ||
|---|---|---|---|
| Total patients | 173 (79.36%) | 45 (20.64%) | |
| Gender | 0.244 | ||
| Male | 86 (49.71%) | 27 (60.00%) | |
| Female | 87 (50.29%) | 18 (40.00%) | |
| Age in years | 55.25 | 61.33 | 0.048 |
| BMI in kg/m2 | 26.86 | 28.16 | 0.173 |
| Medical history | 72 (41.86%) | 27 (60.00%) | 0.043 |
| Diabetes mellitus | 21 (12.21%) | 12 (26.67%) | |
| Cancer | 20 (11.63%) | 7 (15.56%) | |
| Other immunosuppressive disease | 11 (6.40%) | 7 (15.56%) | |
| Focus | * < 0.001 | ||
| Tonsils | 13 (7.56%) | 25 (55.56%) | |
| Teeth | 25 (14.53%) | 7 (15.56%) | |
| Salivary gland | 33 (19.19%) | 0 | |
| Other | 53 (30.81%) | 13 (28.89%) | |
| No focus identified | 48 (27.91%) | 0 | |
| Initial inflammation values | |||
| Leukocytes in 1000/µl | 13.45 | 17.39 | 0.105 |
| CRP in mg/dl | 10.41 | 26.09 | * < 0.001 |
| PCT in ng/ml | 0.33 | 10.76 | * < 0.001 |
Values are given in number (proportion) or mean
BMI body mass index, CRP C-reactive protein, PCT procalcitonin
*Indicates significance after Bonferroni correction
Fig. 1Distribution of the abscess localizations. Because of multi-space involvement, the total number exceeds the 218 patients
Microbacterial results in patients with and without mediastinal involvement of deep neck infections
| No mediastinal involvement | mediastinal involvement | |||
|---|---|---|---|---|
| 37 | 21.2% | 18 | 40% | |
| 25 | 14.1% | 4 | 8.9% | |
| ß-hemolytic streptococci | 13 | 7.5% | 9 | 20% |
| Coagulase-negative staphylococcus | 9 | 5.2% | 4 | 8.9% |
| 5 | 2.9% | 2 | 4.4% | |
| 3 | 1.7% | 4 | 8.9% | |
| 4 | 2.3% | 2 | 4.4% | |
| 4 | 2.3% | 0 | 0 | |
| Enterobacteriaceae | 0 | 0 | 4 | 8.9% |
| Other | 15 | 8.7% | 14 | 31.1% |
| Multidrug-resistant organisms (MDRO) | 2 | 1.2% | 4 | 8.9% |
| No bacterial growth in culture | 69 | 39.9% | 10 | 22.2% |
| Polymicrobial | 10 | 5.8% | 18 | 40% |
Values are given in numbers and proportion. Proportions can exceed 100% due to polymicrobial infections
Diagnostic, therapy and clinical course of patients with or without mediastinal involvement in deep neck infections
| No mediastinal involvement | Mediastinal involvement | OR (95% CI) | ||
|---|---|---|---|---|
| Number of CT-scans | 0.85 | 3.58 | * < 0.001 | |
| Hospitalization in days | 9.79 | 39.78 | * < 0.001 | |
| Antibiotic therapy in days | 8.98 | 30.11 | * < 0.001 | |
| Empiric therapy suitable for pathogen | 161 (93.06%) | 33 (73.33%) | * < 0.001 | 5.32 (2.16–13.09) |
| Need for a change of antibiotic regimen | 11 (6.36%) | 20 (44.44%) | * < 0.001 | 11.71 (5.01–27.34) |
| Number of surgeries | 1.11 | 4.27 | * < 0.001 | |
| Need for transthoracic surgery | 0 | 5 (11.11%) | ||
| Wound lavage in days | 4.06 | 11.78 | * < 0.001 | |
| Mortality | 0 | 4 (8.89%) | *0.002 | 37.63 (1.99–713.2) |
| Necrotizing fasciitis | 0 | 9 (20.00%) | * < 0.001 | 90.32 (5.14–1588) |
| Tracheotomy | 6 (3.47%) | 37 (82.22%) | * < 0.001 | 128.7 (42.12–393.4) |
Values are given in numbers (proportion) or mean. For categorical data, odds ratio with the respective 95% confidence interval have been calculated
*Indicates significance after Bonferroni correction
Risk factors for long hospitalization, more surgeries and tracheotomy for all patients
| Long hospitalization | Number of surgeries | Tracheotomy | ||||
|---|---|---|---|---|---|---|
| OR (95% CI) | OR (95% CI) | OR (95% CI) | ||||
| Age > 60 years | 0.048 | 1.79 (1.03–3.13) | 0.205 | 1.56 (0.84–2.91) | *0.007 | 2.61 (1.30–5.23) |
| BMI > 30 kg/m2 | 0.055 | 1.86 (1.00–3.45) | 0.357 | 1.42 (0.70–2.87) | 0.705 | 1.15 (0.55–2.41) |
| Mediastinal involvement | * < 0.001 | 32.44 (10.95–96.10) | * < 0.001 | 137.5 (42.14–448.7) | * < 0.001 | 128.7 (42.12–393.4) |
| Initial CRP > 10.00 mg/dl | * < 0.001 | 6.34 (3.41–11.79) | * < 0.001 | 4.88 (2.38–9.99) | * < 0.001 | 11.68 (4.38–31.13) |
| Initial PCT > 0.50 ng/ml | * < 0.001 | 21.71 (7.30–64.59) | * < 0.001 | 11.20 (5.20–24.15) | * < 0.001 | 25.24 (10.42–61.09) |
| Medical history | * < 0.001 | 2.78 (1.58–4.90) | 0.017 | 2.24 (1.186–4.23) | *0.004 | 2.83 (1.40–5.72) |
For OR-analysis, the items age, BMI, initial CRP and initial PCT have been converted to binaries by defining cut-off values
BMI body mass index, CRP C-reactive protein, PCT procalcitonin
*Indicates significance after Bonferroni correction
Fig. 2Proposed algorithm for diagnostic and treatment of cervical abscesses